In keeping with Oxford Global’s highly successful life sciences series, an expert panel of over 30 speakers will present a full conference programme covering the topics outlined below.
Advances in Immuno-oncology Congress
Day 1 Stream 1 – Discovery and Early Development of Immuno-oncology Therapies
– CAR T cell therapies
– Adoptive cell transfer
– Cancer vaccines & oncolytic viral therapies
– Immune receptor agonist antibodies
– BiTe (Bispecific T Cell Engagers)
Advances in Immuno-oncology Congress
Day 1 Stream 1 – Discovery and Early Development of Immuno-oncology Therapies
- Key therapeutic strategies in immuno-oncology
– CAR T cell therapies
– Adoptive cell transfer
– Cancer vaccines & oncolytic viral therapies
– Immune receptor agonist antibodies
– BiTe (Bispecific T Cell Engagers)
- Targeting the PD-1 pathway and finding alternative therapeutic targets
- Novel technologies to enhance discovery of immunotherapies in oncology
- Molecular oncology updates including B cells
- Approaches to clinical trial design & development
- Key safety challenges in cancer immunotherapy clinical trials
- Strategies for effective trial management
- Clinical data & case studies
- Clinical immuno-oncology combinations in different cancers and tumour types
- Establishing partnerships and collaborations
- Biomarkers in immuno-oncology
- Clinical diagnostics & the potential of NGS in immuno-oncology clinical trials
- Preclinical models including humanised mouse models
- Preclinical assay development
- Translational strategies
- Approaches to preclinical combination therapy design
- Reducing toxicity challenges in immuno-oncology therapeutics
- Innovative technologies for immunotherapy
